The global veterinary vaccine adjuvants market is experiencing strong growth, with sales estimated to reach USD 431.4 million in 2024 and projected to grow to USD 674.2 million by 2034. This growth represents a compound annual growth rate (CAGR) of 4.6% over the forecast period. In 2023, the market generated USD 412.7 million in revenue, reflecting continued demand for advanced solutions in animal health and disease prevention.

The rapid expansion of the livestock and poultry sectors to meet increasing global food consumption is driving this market growth. As animal health becomes a more prominent concern worldwide, the demand for vaccines and adjuvants to prevent diseases has surged. Additionally, increasing awareness of zoonotic diseases—those that can be transmitted between animals and humans—is highlighting the importance of effective, high-quality vaccines. This shift in focus is encouraging the development of novel adjuvants that enhance the efficacy of vaccines, which is further fueling market demand.

Get Access to Sample Report Now! https://www.futuremarketinsights.com/report-sample#5245502d47422d3139383637

The rise in pet ownership and the growing focus on preventive care in the pet industry is another key factor supporting the expansion of veterinary vaccine adjuvants. Pet owners are increasingly seeking solutions to protect their animals from disease, which has led to a surge in research and development of adjuvants tailored to companion animals. This trend is expected to add significant momentum to the market in the coming years.

As the demand for vaccines and adjuvants grows, the industry is likely to see further innovation and investment in research to meet the needs of both livestock and companion animal sectors.

“The veterinary vaccine adjuvants market is poised for robust growth, driven by both the expanding agricultural sector and the increasing focus on pet health, the continuous advancements in adjuvant technology, aimed at enhancing vaccine effectiveness, will play a pivotal role in shaping the future of veterinary medicine.” said opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).

Key Takeaways:

• The global veterinary vaccine adjuvants market was valued at USD 412.7 million in 2023.
• The market is expected to grow to USD 431.4 million in 2024.
• The market is projected to reach USD 674.2 million by 2034.
• The market is expected to grow at a 4.6% CAGR during the forecast period from 2024 to 2034.

• United States: Anticipated to exhibit a 2.6% Value CAGR from 2024 to 2034.
• China: Expected to show a strong 7.5% Value CAGR during the same period.
• Germany: Projected to grow at a 2.3% Value CAGR from 2024 to 2034.
• India: Expected to show the highest growth, with a 7.8% Value CAGR from 2024 to 2034.
• South Korea: Anticipated to grow at 7.1% Value CAGR during the forecast period.

• Mineral salts dominate the veterinary vaccine adjuvants market, holding a 53.7% market share.
• Livestock animals represent 70.1% of the market share and are expected to drive significant growth during the forecast period.

Increased Market Insight Demand: Get Thorough Analysis and Trends in Our Complete Report! https://www.globenewswire.com/news-release/2024/11/18/2982988/0/en/Global-Veterinary-Vaccine-Adjuvants-Market-to-Reach-USD-674-2-Million-by-2034-Driven-by-Rising-Demand-for-Animal-Health-Solutions-FMI.html

Competitive Landscape:

The veterinary vaccine adjuvants market is highly competitive, with key players focusing on innovation and expanding infrastructure to meet increasing industry demands. Companies are developing specialized adjuvants for different animal categories, enhancing vaccine effectiveness, and addressing emerging health concerns.

At the same time, significant investments in cutting-edge manufacturing facilities demonstrate a commitment to scaling production and ensuring a consistent supply of high-quality adjuvant ingredients. This competitive environment underscores a strategic focus on evolving customer needs and maintaining technological leadership in the sector.

Recent Industry Developments in the Veterinary Vaccine Adjuvants Market:

• In June 2023, Croda, Inc. announced the opening of a 23,680-square-foot facility dedicated to the production of ingredients for drug delivery systems.
• On April 29, 2020, Seppic launched MONTANIDE™ ISA 78 VG, an advanced adjuvant designed specifically for poultry vaccines. This innovative adjuvant boosts immune responses in poultry, addressing the growing demand for more effective vaccine solutions in the industry.

Key Players of Veterinary Vaccine Adjuvants Industry:

• SEPPIC (Air Liquide)
• Phibro Animal Health Corporation
• InvivoGen
• SPI Pharma (Associated British Foods Plc.)
• Croda International Plc
• Evonik Industries AG
• OZ Biosciences
• Creative Biogene
• Creative Biolabs
• Novavax
• Edinburgh Innovations
• Innaxon
• Merck & Co., Inc. (MSD Animal Health)

Key Segments of Veterinary Vaccine Adjuvants Industry:

By Technology:

In terms of technology, the industry is divided into mineral salt (aluminum salt, calcium phosphate), emulsions (oil-in-water (o/w) emulsions, water-in-oil (w/o) emulsions), saponins, toll-like receptor (TLR) agonists, cytokines, polymers (natural, synthetic), liposomes, other

By Animal:

In terms of animal, the industry is divided into companion animals, livestock animals and aquaculture

By Vaccine Type:

In terms of vaccine type, the industry is divided into inactivated vaccines, subunit vaccines, toxoid vaccines and DNA vaccines

By Route of Administration:

In terms of route of administration, the industry is divided into oral route, mucosal, intramuscular, subcutaneous and others

By End User:

In terms of end user, the industry is divided into educational & research institutes, biopharmaceutical companies, contract development & manufacturing organizations and others end users.

By Region:

Key countries of North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube